KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Intangibles (2018 - 2025)

BioNTech SE's Intangibles history spans 8 years, with the latest figure at $1.9 billion for Q4 2025.

  • On a quarterly basis, Intangibles rose 121.34% to $1.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 billion, a 121.34% increase, with the full-year FY2025 number at $1.8 billion, up 114.83% from a year prior.
  • Intangibles hit $1.9 billion in Q4 2025 for BioNTech SE, up from $1.6 billion in the prior quarter.
  • Over the last five years, Intangibles for BNTX hit a ceiling of $1.9 billion in Q4 2025 and a floor of -$78.5 million in Q4 2022.
  • Historically, Intangibles has averaged $710.9 million across 5 years, with a median of $635.2 million in 2023.
  • Biggest five-year swings in Intangibles: tumbled 218.66% in 2022 and later skyrocketed 1202.72% in 2023.
  • Tracing BNTX's Intangibles over 5 years: stood at $66.1 million in 2021, then tumbled by 218.66% to -$78.5 million in 2022, then skyrocketed by 1202.72% to $865.2 million in 2023, then fell by 2.37% to $844.6 million in 2024, then surged by 121.34% to $1.9 billion in 2025.
  • Business Quant data shows Intangibles for BNTX at $1.9 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.7 billion in Q2 2025.